Nova Patents
IL195352A0

Use of cladibrine and ifn in the manufacture of a composition for treating multiple sclerosis

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

47 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
06114537European Patent Office (EPO)A
84547006United States of AmericaP
2007055013European Patent Office (EPO)W

Members47

Family members, oldest first
DocumentOfficeKind
AU2007253254A1AustraliaA1
CA2649810A1CanadaA1
WO2007135172A2World Intellectual Property Organization (WIPO)A2
WO2007135172A3World Intellectual Property Organization (WIPO)A3
AR061122A1ArgentinaA1
MX2008014971AMexicoA
ECSP088997AEcuadorA
EP2026832A2European Patent Office (EPO)A2
KR20090019810ARepublic of KoreaA
EA200802247A1Eurasian Patent Organization (EAPO)A1
CN101500598AChinaA
HK1127753AHong Kong, ChinaA
HK1127753A1Hong Kong, ChinaA1
JP2009537605AJapanA
ZA200808852BSouth AfricaB
US2010021429A1United States of AmericaA1
IL195352A0This recordIsraelA0
IL195352D0IsraelD0
BRPI0710326A2BrazilA2
NZ572680ANew ZealandA
UA96941C2UkraineC2
EP2026832B1European Patent Office (EPO)B1
AT555804TAustriaT
ATE555804T1AustriaT1
PT2026832EPortugalE
DK2026832T3DenmarkT3
HRP20120382T1CroatiaT1
ES2384399T3SpainT3
SI2026832T1SloveniaT1
PL2026832T3PolandT3
AU2007253254B2AustraliaB2
RS52424BSerbiaB
MY149042AMalaysiaA
JP2014208662AJapanA
EA020805B1Eurasian Patent Organization (EAPO)B1
JP2016128443AJapanA
US9925151B2United States of AmericaB2
JP2018080184AJapanA
US2018207109A1United States of AmericaA1
JP6542680B2JapanB2
US10555913B2United States of AmericaB2
JP2020050651AJapanA
US2020155477A1United States of AmericaA1
JP7132194B2JapanB2
JP2022162108AJapanA
US12377056B2United States of AmericaB2
US20260014097A1United States of AmericaA1